The Retro-Futurismof Teeth Cleaning.
Chegus Ventures is replacing the world's most toxic daily ritual with a 100% biocompatible, silica-based science validated at the molecular level.
Clinical research validated by JSS Dental College & Hospital and the National Centre for Biological Sciences.
Our Mission
"We are not building a better toothpaste. We are ending the era of toothpaste."
Bengaluru-based consumer health & biotech company disrupting a $50B+ global oral care market through 100% biocompatible, upcycled silica science.
The Science
Three pillars of a paradigm shift.
Biomimetic Remineralisation
Our silica-based formula follows the hydroxyapatite pathway — the same mineral that constitutes 97% of tooth enamel. Unlike fluoride, which forms a foreign fluorapatite layer, our RHA silica integrates at the molecular level, rebuilding enamel as nature intended.
Zero Toxicity
Every ingredient is 100% biocompatible. Our tooth powder is derived from upcycled rice husk ash — a circular, zero-waste process that transforms agricultural byproduct into pharmaceutical-grade amorphous silica. No fluoride. No SLS. No microplastics.
Clinically Validated
Rigorous clinical pilot studies conducted with JSS Dental College & Hospital and foundational molecular research at the National Centre for Biological Sciences (NCBS) confirm superior anti-bacterial performance, measurable plaque reduction, and biomimetic enamel remineralization.
Product Ecosystem
Three products. One complete system.
RHA Tooth Powder
Pharmaceutical-grade amorphous silica from upcycled rice husk ash. The world's first truly biocompatible tooth powder — zero fluoride, zero SLS, zero compromise.
Novel Toothbrush
Automated Dispenser
Research & Validation
Science Validated at the Highest Level
Our clinical outcomes are not projections. They are peer-reviewed results from India's most respected dental and biological sciences institutions.
Clinical Pilot Studies
JSS Dental College & Hospital
Foundational Molecular Research · NCBS, Bengaluru
National Centre for Biological Sciences
All clinical outcomes are derived from peer-reviewed pilot studies and institutional research. Results confirm superior anti-bacterial performance, measurable plaque reduction, and biomimetic enamel remineralization.
Download Science Brief
The Retro-Futurism of Teeth Cleaning · PDF
Investor Relations
Built for Global Scale.
Seeking Strategic Partners.
- $50B+ global oral care market ripe for biocompatible disruption
- Proprietary RHA silica IP with clinical validation and NCBS research backing
- Top-to-bottom pyramid strategy targeting premium western markets first
Strategic Partnerships
Connect With Our Team
We are actively seeking institutional investors, global distribution partners, and strategic co-development relationships. Reach our leadership directly.
Connect With Our Team